• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铅诱导脉络丛中β-淀粉样蛋白的积累:低密度脂蛋白受体蛋白-1 和蛋白激酶 C 的作用。

Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.

机构信息

School of Health Sciences, Purdue University, West Lafayette, IN 47907, USA.

出版信息

Neurotoxicology. 2010 Sep;31(5):524-32. doi: 10.1016/j.neuro.2010.05.004. Epub 2010 May 19.

DOI:10.1016/j.neuro.2010.05.004
PMID:20488202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2934890/
Abstract

The choroid plexus (CP), constituting the blood-cerebrospinal fluid barrier, has the capacity to remove beta-amyloid (Abeta) from the cerebrospinal fluid. Our previous work indicates that exposure to lead (Pb) results in Abeta accumulation in the CP by decreasing the expression of low density lipoprotein receptor protein-1 (LRP1), a protein involved in the transport and clearance of Abeta. The current study was designed to explore the relationship between Abeta accumulation, protein kinase C (PKC) activity, and LRP1 status in the CP following Pb exposure. Confocal microscopy revealed that LRP1 was primarily localized in the cytosol of the CP in control rats and migrated distinctly towards the apical surface and the microvilli following acute Pb exposure (27 mg Pb/kg, i.p., 24h). Co-immunostaining revealed a co-localization of both PKC-delta and LRP1 in the cytosol of control rats, with a distinct relocalization of both towards the apical membrane following Pb exposure. Preincubation of the tissues with PKC-delta inhibitor rottlerin (2 microM) prior to Pb exposure in vitro, resulted in abolishing the Pb-induced relocalization of LRP1 to the apical surface. Importantly, a significant elevation in intracellular Abeta levels (p<0.01) was observed in the cytosol of the CP following Pb exposure, which was abolished following preincubation with rottlerin. In addition, rottlerin caused a relocalization of Abeta from the cytosol to the nucleus in both Pb-treated and control CP tissues. Finally, co-immunoprecipitation studies revealed a strong protein-protein interaction between LRP1 and PKC-delta in the CP. These studies suggest that Pb exposure disrupts Abeta homeostasis at the CP, owing partly to a Pb-induced relocalization of LRP1 via PKC-delta.

摘要

脉络丛(CP)构成了血脑屏障,具有从脑脊液中清除β-淀粉样蛋白(Abeta)的能力。我们之前的工作表明,暴露于铅(Pb)会通过降低低密度脂蛋白受体蛋白-1(LRP1)的表达来导致 CP 中 Abeta 积累,LRP1 是一种参与 Abeta 转运和清除的蛋白。本研究旨在探讨 Pb 暴露后 CP 中 Abeta 积累、蛋白激酶 C(PKC)活性和 LRP1 状态之间的关系。共聚焦显微镜显示,LRP1 在对照组大鼠的 CP 细胞质中主要定位于细胞质中,在急性 Pb 暴露后(27mg Pb/kg,腹腔内,24h)明显迁移到顶表面和微绒毛。共免疫染色显示,PKC-delta 和 LRP1 在对照组大鼠的细胞质中均有共定位,在 Pb 暴露后明显向顶膜重新定位。在体外 Pb 暴露之前,用 PKC-delta 抑制剂 rottlerin(2μM)预孵育组织,导致 LRP1 向顶表面的 Pb 诱导重新定位消失。重要的是,在 CP 细胞质中观察到 Abeta 水平的显著升高(p<0.01)在 Pb 暴露后,在用 rottlerin 预孵育后消失。此外,rottlerin 导致 Abeta 从 CP 中细胞质到细胞核的重新定位在 Pb 处理和对照 CP 组织中均发生。最后,免疫共沉淀研究表明 LRP1 和 PKC-delta 在 CP 之间存在很强的蛋白-蛋白相互作用。这些研究表明,Pb 暴露破坏了 CP 中的 Abeta 动态平衡,部分原因是 Pb 诱导的 LRP1 通过 PKC-delta 重新定位。

相似文献

1
Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.铅诱导脉络丛中β-淀粉样蛋白的积累:低密度脂蛋白受体蛋白-1 和蛋白激酶 C 的作用。
Neurotoxicology. 2010 Sep;31(5):524-32. doi: 10.1016/j.neuro.2010.05.004. Epub 2010 May 19.
2
Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.铅暴露后脉络丛中β-淀粉样蛋白水平升高及低密度脂蛋白受体蛋白-1的作用。
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):245-54. doi: 10.1016/j.taap.2009.05.024. Epub 2009 Jun 6.
3
Altered clearance of beta-amyloid from the cerebrospinal fluid following subchronic lead exposure in rats: Roles of RAGE and LRP1 in the choroid plexus.大鼠亚慢性铅暴露后脑脊液中β-淀粉样蛋白清除的改变:脉络丛中晚期糖基化终末产物受体(RAGE)和低密度脂蛋白受体相关蛋白1(LRP1)的作用
J Trace Elem Med Biol. 2020 Apr 8;61:126520. doi: 10.1016/j.jtemb.2020.126520.
4
Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.铅暴露会增加大脑和脑脊液中的 β-淀粉样蛋白水平,并抑制 APP 转基因小鼠中的 LRP1 表达。
Neurosci Lett. 2011 Feb 18;490(1):16-20. doi: 10.1016/j.neulet.2010.12.017. Epub 2010 Dec 16.
5
High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.β-淀粉样蛋白与脑毛细血管的高亲和力:慢性铅暴露诱导大鼠神经毒性的影响。
Fluids Barriers CNS. 2023 May 1;20(1):32. doi: 10.1186/s12987-023-00432-5.
6
Lead exposure promotes translocation of protein kinase C activities in rat choroid plexus in vitro, but not in vivo.铅暴露可促进体外培养的大鼠脉络丛中蛋白激酶C活性的易位,但在体内则不然。
Toxicol Appl Pharmacol. 1998 Mar;149(1):99-106. doi: 10.1006/taap.1997.8352.
7
The role of choroid plexus in IVIG-induced beta-amyloid clearance.脉络丛在静脉注射免疫球蛋白诱导的β-淀粉样蛋白清除中的作用。
Neuroscience. 2014 Jun 13;270:168-176. doi: 10.1016/j.neuroscience.2014.04.011. Epub 2014 Apr 16.
8
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.抑制ADAM10通过减少低密度脂蛋白受体相关蛋白1(LRP1)胞外域脱落来促进β淀粉样蛋白(Aβ)通过血脑屏障的清除。
Fluids Barriers CNS. 2016 Aug 8;13(1):14. doi: 10.1186/s12987-016-0038-x.
9
Upregulation of zinc transporter 2 in the blood-CSF barrier following lead exposure.血脑屏障中锌转运蛋白 2 在外源性铅暴露后的上调。
Exp Biol Med (Maywood). 2014 Feb;239(2):202-12. doi: 10.1177/1535370213509213. Epub 2013 Dec 5.
10
Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure.胰岛素降解酶在血脑-脊液屏障处β-淀粉样蛋白清除中的作用:铅暴露的影响。
Cerebrospinal Fluid Res. 2009 Sep 11;6:11. doi: 10.1186/1743-8454-6-11.

引用本文的文献

1
Metabolite transport across central nervous system barriers.代谢物穿过中枢神经系统屏障的转运。
J Cereb Blood Flow Metab. 2024 Jul;44(7):1063-1077. doi: 10.1177/0271678X241241908. Epub 2024 Mar 28.
2
An efficient autometallography approach to localize lead at ultra-structural levels of cultured cells.一种在培养细胞超微结构水平上定位铅的高效自动金属显影方法。
Biophys Rep. 2020 Oct 31;6(5):211-221. doi: 10.1007/s41048-020-00116-9.
3
Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases.金属神经毒性中的小胶质细胞激活:对神经退行性疾病的影响。

本文引用的文献

1
Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.铅暴露后脉络丛中β-淀粉样蛋白水平升高及低密度脂蛋白受体蛋白-1的作用。
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):245-54. doi: 10.1016/j.taap.2009.05.024. Epub 2009 Jun 6.
2
Gamma-secretase limits the inflammatory response through the processing of LRP1.γ-分泌酶通过对低密度脂蛋白受体相关蛋白1(LRP1)的加工处理来限制炎症反应。
Sci Signal. 2008 Nov 25;1(47):ra15. doi: 10.1126/scisignal.1164263.
3
Amyloid-beta dynamics correlate with neurological status in the injured human brain.
Biomed Res Int. 2023 Jan 31;2023:7389508. doi: 10.1155/2023/7389508. eCollection 2023.
4
Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies.重金属诱导的脑小血管病:分子机制与可能逆转策略的研究进展。
Int J Mol Sci. 2020 May 29;21(11):3862. doi: 10.3390/ijms21113862.
5
Childhood Lead Exposure and Adult Neurodegenerative Disease.儿童期铅暴露与成人神经退行性疾病。
J Alzheimers Dis. 2018;64(1):17-42. doi: 10.3233/JAD-180267.
6
Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.人脑血脑屏障中与β淀粉样肽清除相关转运体的免疫组织化学分析
Histochem Cell Biol. 2015 Dec;144(6):597-611. doi: 10.1007/s00418-015-1366-7. Epub 2015 Oct 8.
7
Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.剖析血管改变和衰老对阿尔茨海默病的影响
Mol Neurobiol. 2016 Aug;53(6):3793-3811. doi: 10.1007/s12035-015-9319-7. Epub 2015 Jul 5.
8
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.环境污染物作为神经退行性疾病的风险因素:阿尔茨海默病和帕金森病
Front Cell Neurosci. 2015 Apr 10;9:124. doi: 10.3389/fncel.2015.00124. eCollection 2015.
9
Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.脉络丛功能障碍损害阿尔茨海默病三联转基因小鼠模型中的β-淀粉样蛋白清除。
Front Cell Neurosci. 2015 Feb 6;9:17. doi: 10.3389/fncel.2015.00017. eCollection 2015.
10
Stress-induced stimulation of choline transport in cultured choroid plexus epithelium exposed to low concentrations of cadmium.镉低浓度暴露培养脉络丛上皮细胞胆碱转运的应激刺激。
Am J Physiol Regul Integr Comp Physiol. 2014 Mar 1;306(5):R291-303. doi: 10.1152/ajpregu.00252.2013. Epub 2014 Jan 8.
β-淀粉样蛋白动力学与人类受伤大脑的神经状态相关。
Science. 2008 Aug 29;321(5893):1221-4. doi: 10.1126/science.1161591.
4
Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy.职业性接触铅的工人海马体积和脑代谢物改变的证据:一项磁共振成像和氢质子磁共振波谱研究
Toxicol Lett. 2008 Sep 26;181(2):118-25. doi: 10.1016/j.toxlet.2008.07.009. Epub 2008 Jul 23.
5
The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.细胞表面低密度脂蛋白受体相关蛋白(LRP)和可溶性LRP在阿尔茨海默病血脑屏障β淀粉样蛋白清除中的作用
Curr Pharm Des. 2008;14(16):1601-5. doi: 10.2174/138161208784705487.
6
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.直接从阿尔茨海默病患者大脑中分离出的β-淀粉样蛋白二聚体损害突触可塑性和记忆。
Nat Med. 2008 Aug;14(8):837-42. doi: 10.1038/nm1782. Epub 2008 Jun 22.
7
The environment, epigenetics and amyloidogenesis.环境、表观遗传学与淀粉样蛋白生成
J Mol Neurosci. 2008;34(1):1-7. doi: 10.1007/s12031-007-0009-4. Epub 2007 Apr 17.
8
Lead and cognitive function in adults: a questions and answers approach to a review of the evidence for cause, treatment, and prevention.成人铅与认知功能:关于病因、治疗及预防证据综述的问答式探讨
Int Rev Psychiatry. 2007 Dec;19(6):671-92. doi: 10.1080/09540260701797936.
9
New and evolving concepts in the neurotoxicology of lead.铅神经毒理学中的新观念与发展中的概念
Toxicol Appl Pharmacol. 2007 Nov 15;225(1):1-27. doi: 10.1016/j.taap.2007.08.001. Epub 2007 Aug 16.
10
Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.蛋白激酶Cδ抑制剂rottlerin在帕金森病细胞培养和动物模型中的神经保护作用。
J Pharmacol Exp Ther. 2007 Sep;322(3):913-22. doi: 10.1124/jpet.107.124669. Epub 2007 Jun 12.